Evidence map›Paper›PMID 40853976›Full record

ArticlePLoS genetics2025

Tissue-specific consequences of tag fusions on protein expression in transgenic mice.

Gillian C A Taylor, Lewis Macdonald, Natalia A Szulc, Evelina Gudauskaite, Brianda Hernandez Moran, Jennifer M Brisbane, Molly Donald, Ella Taylor, Dejin Zheng, Bin Gu and 5 more

Abstract read
In one paragraph

Article in PLoS genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Gillian C A TaylorMRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, United Kingdom.ORCID https://orcid.org/0009-0005-7475-2250
Lewis MacdonaldMRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, United Kingdom.
Natalia A SzulcLaboratory of Protein Metabolism, International Institute of Molecular and Cell Biology in Warsaw, Warsaw, Poland.ORCID https://orcid.org/0000-0002-2991-3634
Evelina GudauskaiteMRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, United Kingdom.
Brianda Hernandez MoranMRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, United Kingdom.ORCID https://orcid.org/0000-0001-5405-0757
Jennifer M BrisbaneMRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, United Kingdom.ORCID https://orcid.org/0000-0003-4943-5331
Molly DonaldMRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, United Kingdom.ORCID https://orcid.org/0009-0004-0098-5791
Ella TaylorImmunology Programme, The Babraham Institute, Babraham Research Campus, Cambridge, United Kingdom.
Dejin ZhengDepartment of Obstetrics, Gynecology and Reproductive Biology, Michigan State University, East Lansing, Michigan, United States of America.ORCID https://orcid.org/0000-0002-6969-1650
Bin GuDepartment of Obstetrics, Gynecology and Reproductive Biology, Michigan State University, East Lansing, Michigan, United States of America.
Pleasantine MillMRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, United Kingdom.ORCID https://orcid.org/0000-0001-5218-134X
Patricia L YeyatiMRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, United Kingdom.ORCID https://orcid.org/0000-0001-5094-5182
Wojciech PokrzywaLaboratory of Protein Metabolism, International Institute of Molecular and Cell Biology in Warsaw, Warsaw, Poland.
Claudia Ribeiro de AlmeidaImmunology Programme, The Babraham Institute, Babraham Research Campus, Cambridge, United Kingdom.ORCID https://orcid.org/0000-0002-1462-5453
Andrew J WoodMRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, United Kingdom.ORCID https://orcid.org/0000-0002-0653-2070

Funding

Developing a clinically-relevant genetically engineered mouse model for Nut carcinomaR37CA269076 · NCI · MICHIGAN STATE UNIVERSITY · PI Bin Gu · 2023 to 2026
$1.7M
Developing humanized Nut Carcinoma mouse model for developing NUTM1 targeted therapies.R03CA286646 · NCI · HENRY FORD HEALTH + MICHIGAN STATE UNIVERSITY HEALTH SCIENCES · PI GU, BIN · 2024 to 2025
$157k
NCI NIH HHS R03 CA286646NCI NIH HHS R37 CA269076Wellcome Trust
6 · The paper itself

Abstract

Genetic fusion of protein tags is widely used to study protein functions in vivo. It is well known that tag fusion can cause unwanted changes in protein stability, but whether this is an inherent property of the tagged protein, or can be influenced by the cell and tissue environment, is unclear. Using a series of genome edited mouse models, we show that tag-dependent changes in protein expression can vary across different primary cell and tissue contexts. In one case (Ncaph2), a C-terminal auxin-inducible degron fusion strongly increased protein stability in some tissues but decreased it in others. Destabilisation resulted from tissue-specific 'leakage' of the auxin-inducible degron, which depended on TIR1 expression, and occurred selectively in the small intestine where basal concentrations of auxin/ indole-3-acetic acid can reach levels that are sufficient to trigger protein degradation in cultured cells. Stabilisation occurred in post-mitotic cells via an endogenous degradation signal situated at the NCAPH2 C-terminus, which normally undergoes activation upon cell cycle exit, but is inactivated by C-terminal tag fusion. Our results highlight the underappreciated importance of cell and tissue environment in determining the consequences of tag fusions on protein expression, which may be particularly important in animal models that contain diverse cell types.

Indexed as

Homeodomain ProteinsRecombinant Fusion ProteinsAnimalsHumansIndoleacetic AcidsIntestine, SmallMiceMice, TransgenicOrgan SpecificityProtein StabilityProteolysisHomeodomain Proteinsindoleacetic acidIndoleacetic AcidsRecombinant Fusion Proteins

Identifiers

PMID40853976
PMCPMC12407551

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.